These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6208273)

  • 1. Biochemical and functional evidence that an MT3 supertypic determinant defined by a monoclonal antibody is carried on the DR molecule on HLA-DR7 cell lines.
    Horibe K; Flomenberg N; Pollack MS; Adams TE; Dupont B; Knowles RW
    J Immunol; 1984 Dec; 133(6):3195-202. PubMed ID: 6208273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
    Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
    J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new supertypic HLA class II determinant (PL2) differentially expressed with DR7, DRw11(5), DRw13(w6), DRw14(w6), DR3, and DR2 and biochemically localized to DR7 molecules.
    Horibe K; Knowles RW; Dupont B
    Hum Immunol; 1986 May; 16(1):14-23. PubMed ID: 2423484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the MT3 molecule from HLA-DR4, 7, and w9 homozygous cell lines.
    Mukai R; Suzuki M; Yabe T; Hamaguchi H; Maeda H
    J Immunol; 1984 Dec; 133(6):3211-9. PubMed ID: 6436378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of three class II antigens, DR7, MB2, and MT3, from a homozygous human cell line.
    Shackelford DA; Strominger JL
    Hum Immunol; 1984 Mar; 9(3):159-74. PubMed ID: 6199337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural relationships between the DR beta 1 and DR beta 2 subunits in DR4, 7, and w9 haplotypes and the DRw53 (MT3) specificity.
    Matsuyama T; Schwenzer J; Silver J; Winchester R
    J Immunol; 1986 Aug; 137(3):934-40. PubMed ID: 2424991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the MT3 molecule using two-dimensional gel electrophoresis and alloantisera.
    Suzuki M; Maeda H; Mukai R; Yabe T; Hamaguchi H
    Immunogenetics; 1983; 18(6):575-83. PubMed ID: 6197369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MT3 specificity resides on a novel human class II antigen distinct from the HLA-DR antigen and DC-like antigen.
    Yabe T; Suzuki M; Satake M; Juji T; Hamaguchi H
    Immunogenetics; 1984; 20(2):155-67. PubMed ID: 6205988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-specific HLA-restricted human T-cell lines. I. An MT3-like restriction determinant distinct from HLA-DR.
    Ball EJ; Stastny P
    Immunogenetics; 1984; 19(1):13-26. PubMed ID: 6198272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of MT3 antigens by two-dimensional gel electrophoresis, NH2-terminal amino acid sequence analysis, and southern blot analysis.
    Sorrentino R; Lillie J; Strominger JL
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3794-8. PubMed ID: 2582424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DS molecules and their relation to supertypic specificities.
    Goyert SM; Moriuchi J; Winchester R; Silver J
    Hum Immunol; 1983 Sep; 8(1):53-63. PubMed ID: 6195135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of cross-reactive T cell restriction epitopes located on the DR7 beta 1 and DR beta 4 molecules.
    Bismuth G; Gouy H; Karr RW; Debré P
    Hum Immunol; 1990 Jul; 28(3):271-83. PubMed ID: 1695622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A supertypic HLA-DR specificity (DR4+5) defined by murine monoclonal antibody.
    Hansen JA; Martin PJ; Kamoun M; Nisperos B; Thomas ED
    Hum Immunol; 1981 Mar; 2(2):103-11. PubMed ID: 6167554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
    Maeda H; Hirata R
    J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody recognizing a polymorphic determinant on HLA-DR antigens except DR7 and DRw9.
    Ogasawara K; Kasahara M; Nakayama T; Ishikawa N; Kunikane H; Hawkin S; Kojima H; Ikeda H; Wakisaka A; Kikuchi Y
    Tissue Antigens; 1985 Nov; 26(5):344-7. PubMed ID: 2418531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assignment of determinants recognized by human alloantisera to HLA-D-subregion molecules by a lysostrip technique.
    Nuñez G; Stastny P
    Tissue Antigens; 1986 Apr; 27(4):185-95. PubMed ID: 2425451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A monoclonal antibody detecting an HLA-DQwl-related determinant.
    Koning F; Raghoebar J; Schreuder GM; Schuurman R; Bruning H
    Tissue Antigens; 1985 Aug; 26(2):100-9. PubMed ID: 2414859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The monoclonal antibody AC1.59 defines a new polymorphic determinant on HLA-DR molecules.
    Crepaldi T; Richiardi P; Malavasi F; Carbonara AO; Igarashi M; Ferrone S
    Tissue Antigens; 1985 Jul; 26(1):25-34. PubMed ID: 2412306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular localization of human class II MT2 and MT3 determinants.
    Hurley CK; Giles RC; Nunez G; DeMars R; Nadler L; Winchester R; Stastny P; Capra JD
    J Exp Med; 1984 Aug; 160(2):472-93. PubMed ID: 6206179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for the separate molecular expression of four distinct polymorphic Ia epitopes on cells of DR4 homozygous individuals.
    Toguchi T; Burmester G; Nunez-Roldan A; Gregersen P; Seremetis S; Lee S; Szer I; Winchester R
    Hum Immunol; 1984 Jun; 10(2):69-81. PubMed ID: 6203881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.